Title:
NOVEL PEPTIDE AND SCAFFOLD FOR USE IN IMMUNE THERAPY TO NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCER
Document Type and Number:
Japanese Patent JP2022033740
Kind Code:
A
Abstract:
To provide peptide, protein, a nucleic acid and a cell used in immune therapy against cancer.SOLUTION: The present invention provides a tumor-related T cell peptide epitope which is used alone or is combined to other tumor-related peptide. The tumor-related T cell peptide epitope may serve as an active pharmaceutical component of a vaccine composition for stimulating an anti-tumor immune response, or stimulating a T cell in vitro and introducing the T cell to a patient. A peptide coupled to a molecule of a major histocompatibility complex (MHC) or the peptide itself may become a target of an antibody, a soluble T cell receptor and other coupling molecule.SELECTED DRAWING: None
More Like This:
| WO/2015/174862 | POLYNUCLEOTIDE SEQUENCE |
| WO/2012/095548 | DREAM INHIBITORS FOR TREATING NEURODEGENERATIVE DISEASES |
| WO/2020/172218 | ANTIBODIES AND ENONOMERS |
Inventors:
ANDREA MAHR
WEINSCHENK TONI
ANITA WIEBE
COLETTE SONG
SCHOOR OLIVER
JENS FRITSCHE
SINGH HARPREET
WEINSCHENK TONI
ANITA WIEBE
COLETTE SONG
SCHOOR OLIVER
JENS FRITSCHE
SINGH HARPREET
Application Number:
JP2021179862A
Publication Date:
March 02, 2022
Filing Date:
November 02, 2021
Export Citation:
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH
International Classes:
C12N15/115; A61K31/7088; A61K35/15; A61K35/17; A61K38/08; A61K38/10; A61K39/395; A61K48/00; A61P35/00; A61P35/02; C07K14/47; C07K14/725; C07K16/28; C12N5/0783; C12N5/10; C12N15/63; C12P21/02; C12Q1/6874
Domestic Patent References:
| JP2013522276A | 2013-06-13 |
Foreign References:
| WO2003062391A2 | 2003-07-31 | |||
| WO2015193359A2 | 2015-12-23 | |||
| WO2015169945A2 | 2015-11-12 |
Attorney, Agent or Firm:
Go Akatsu